Ascend Clinical Research

Ascend Clinical Research

Quality with Excellence

Major Depressive Disorder - RENEW MDD 2










RENEW - Major Depressive Disorder 2

ABOUT THE STUDY

This clinical study is evaluating whether brenipatide, when added to a participant’s existing stable treatment for Major Depressive Disorder (MDD), may help reduce the risk of depression returning.

The study will compare different doses of brenipatide with placebo to assess how well the treatment helps participants remain stable and avoid a relapse of their depression. Researchers will primarily look at how long participants remain without experiencing a relapse after joining the study.

The information collected during the study will help researchers better understand the potential benefits and safety of brenipatide as an additional treatment option for people living with MDD.

CONTACT INFORMATION

+44 (0) 118 304 5905

+44 (0) 7776 955 230 (Patient Line)

[email protected]

4B Vulcan House (Zone 1 & 2), Calleva Park, Aldermaston,

Reading, UK RG7 8PA

PRIVACY POLICY

Please click here to view our Privacy Policy.

Copyright © 2025 Ascend Clinical Research - All Rights Reserved.